Reuters logo
BRIEF-IPCA Labs says USFDA states drugs from Ratlam facility will be refused admission into U.S.
June 15, 2017 / 1:36 PM / 6 months ago

BRIEF-IPCA Labs says USFDA states drugs from Ratlam facility will be refused admission into U.S.

June 15 (Reuters) - IPCA Laboratories Ltd

* Says US FDA update on company’s active pharmaceutical ingredients manufacturing facility situated at Ratlam (Madhya Pradesh)

* Received exchange from USFDA stating drugs manufactured at MP manufacturing facility will be henceforth refused admission into U.S. Source text: (bit.ly/2tq8S5h) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below